Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × UNKNOWN × Neoplasm Metastasis × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 1/2 1

Status

Sponsor Class

INDUSTRY 169 OTHER 114 NIH 20 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Colorectal Neoplasms 2 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

Oxaliplatin 1 Irinotecan 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04380103 2020-05-08

A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer

ChineseAMS

Phase 1/2 Unknown

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡